These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9238156)

  • 1. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R; Morjani H; Manfait M
    Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
    Belhoussine R; Morjani H; Lahlil R; Manfait M
    Int J Cancer; 1997 Nov; 73(4):600-6. PubMed ID: 9389578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confocal scanning microspectrofluorometry reveals specific anthracyline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells.
    Belhoussine R; Morjani H; Millot JM; Sharonov S; Manfait M
    J Histochem Cytochem; 1998 Dec; 46(12):1369-76. PubMed ID: 9815278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S; Morjani H; Poullain MG; Manfait M
    Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirarubicin nuclear uptake does not correlate with its induced cell death effect during reversal of multidrug resistance by quinine in human K562 and CEM leukemic cells.
    Morjani H; Belhoussine R; Lahlil R; Manfait M
    Eur J Haematol; 1998 Oct; 61(4):240-9. PubMed ID: 9820630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline subcellular distribution in human leukemic cells by microspectrofluorometry: factors contributing to drug-induced cell death and reversal of multidrug resistance.
    Morjani H; Millot JM; Belhoussine R; Sebille S; Manfait M
    Leukemia; 1997 Jul; 11(7):1170-9. PubMed ID: 9205008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines].
    Bennis S; Robert J
    Bull Cancer; 1994 Oct; 81(10):886-90. PubMed ID: 7734772
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
    Huet S; Chapey C; Robert J
    Eur J Cancer; 1993; 29A(10):1377-83. PubMed ID: 8398262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
    Bennis S; Ichas F; Robert J
    Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
    Joly P; Lallemand A; Oum'Hamed Z; Trentesaux C; Idoine O; Desplaces A
    Anticancer Res; 1996; 16(6B):3609-14. PubMed ID: 9042229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of S9788, cyclosporin A and verapamil on intracellular accumulation of doxorubicin, daunorubicin and daunorubicinol in primary rat hepatocyte culture].
    Le Bot MA; Kernaleguen D; Simon I; Berlion M; Riché C
    Ann Biol Clin (Paris); 1996; 54(1):21-4. PubMed ID: 8731791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance.
    Le Bot MA; Kernaleguen D; Robert J; Berlion M; Riché C
    Cancer Chemother Pharmacol; 1994; 35(1):53-8. PubMed ID: 7987977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells.
    Moins N; Cayre A; Chevillard S; Maublant J; Verrelle P; Finat-Duclos F
    Anticancer Res; 2000; 20(4):2617-23. PubMed ID: 10953334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
    Julia AM; Roché H; Berlion M; Lucas C; Milano G; Robert J; Bizzari JP; Canal P
    Br J Cancer; 1994 May; 69(5):868-74. PubMed ID: 8180016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V; Pierré A; Léonce S; Anstett M; Atassi G
    Anticancer Res; 1993; 13(4):985-90. PubMed ID: 8352569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pharmacology of lipophilic anthracyclines in human tumor cells in culture selected for resistance to doxorubicin.
    Bennis S; Faure P; Chapey C; Hu YP; Fourche J; El Yamani J; Robert J
    Anticancer Drugs; 1997 Jul; 8(6):610-7. PubMed ID: 9300576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.